Skip To Main Content
Y.M. Bar-On on Muck Rack

Y.M. Bar-On

As seen in: The New England Journal of Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Y.M.

Contact Y.M., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

|
By REMAP-CAP Investigators, C.-W. Tan, Y.M. Bar-On, M.G. Thompson
| The New England Journal of Medicine Verified
32 References 1 Citing Article Related Articles Abstract Background Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patients who are hospitalized with Covid-19. Methods Download a PDF of the Research Summary.
Open in Who Shared View Duplicates (2) Issue with article?

Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C

|
By Van Lente, C.-W. Tan, Y.M. Bar-On, Yaping Lucy
| The New England Journal of Medicine Verified
25 References 1954 Citing Articles Letters Related Articles Abstract Background Estimates of glomerular filtration rate (GFR) that are based on serum creatinine are routinely used; however, they are imprecise, potentially leading to the overdiagnosis of chronic kidney disease. Cystatin C is an alternative filtration marker for estimating GFR.
Open in Who Shared Issue with article?

Effect of Antibiotic Therapy on the Density of Vancomycin-Resistant Enterococci in the Stool of Colonized Patients

|
By B. B. King, Y.M. Bar-On, D.J. Sullivan
| The New England Journal of Medicine Verified
Characteristics of the Patients A total of 61 inpatients had intestinal colonization with vancomycin-resistant enterococci during the study. Ten of these patients were excluded from the analysis for the following reasons: stool samples from six patients were unavailable, two patients were colonized with E. casseliflavus, and information about antimicrobial therapy was unavailable for two patients. Table 1.
Open in Who Shared Issue with article?
See all 3 articles